Pricing forensics · from the 250-topic plan

First-month discounts, annualized: what the $99 door actually opens

The method: promo once, renewal eleven times

Year-one cost = door price + (11 × renewal rate) + fees the bundle excludes. Three sub-rules make it honest. Use the corridor's realistic point, not its floor — if renewal tiers by dose, the maintenance tier is your planning number, per the ladder piece. Count the excluded lines: memberships, consults, shipping — half-prices presented as whole ones. Then compare against a flat benchmark, because a promo only "saves" relative to something, and the something should be the field's audited floor, not the same program's own strikethrough.

Worked examples, on the record

The $99 promo door. One field program's on-record pattern: ~$99 first month renewing into a $199–$299 corridor. Annualized: $99 + 11×$199 = $2,288 best case; $99 + 11×$299 = $3,388 at the maintenance tier. The door's true function: it moved the purchase decision to a day when the real price wasn't on the page. The tier door. Another program opens near $199 and tiers to $299 — no promo costume, same corridor: a realistic titration year (two entry months, ten at maintenance) lands near $3,388. The commitment door. A ~$165 platform rate that reads like a sticker but carries a twelve-month signature: honest annualization is simply 12×$165 ≈ $1,980 — cheaper than the corridors, dearer than the audited flats, priced in exit freedom. The unpriceable door. An ~$89 semaglutide promo from a seller whose parent company holds a 2026 FDA warning letter: the annualization exercise ends before it starts, because integrity files precede price files — that provider page explains why we won't do the math. The benchmark. Audited flat years: $1,668 tirzepatide, $1,428 semaglutide, dose-proof, all-in, verified 24-for-24 on 2026-08-14. Every door above should be read against these two numbers. The audited flat benchmark ↗

Why doors work on smart people

Anchoring (the $99 sets the reference; the $299 arrives as an exception rather than the rule), present bias (month one is vivid, month seven hypothetical), and switching friction (by renewal, you're titrated, enrolled, and tired — churn is a moat). None of this is illegal; all of it is why the FTC polices deception rather than promotions, and why the annualization habit — not outrage — is the consumer's actual defense.

The two questions that defuse any promo

In writing, before checkout: "What exactly will months two through twelve cost at my maintenance dose, all fees included?" and "If I cancel at month three, what have I paid in total and what do I owe?" A program built on its renewal answers instantly; a program built on its door answers with a link to the promo terms. Either answer tells you everything — and the calculator will run the arithmetic on whatever they send back.

FAQ

How do I calculate the real cost of a first-month GLP-1 discount?

Door price once plus the renewal rate eleven times plus excluded fees — using the maintenance-dose tier where pricing steps with dose. A $99 door into a $199–$299 corridor prices year one at $2,288–$3,388.

Are promo prices ever the better deal?

Occasionally — when the renewal rate itself beats the flat benchmarks. In our field's on-record data, no promo corridor currently renews below the audited $1,428–$1,668 flat years.

What's the fastest tell of an honest program?

It quotes month seven as readily as month one. Door-built programs quote the door.

Sources

• On-record promotional, tiered, and commitment pricing across the field — the open dataset, with source URLs per row.
• Audited flat-rate pricing, verified 2026-08-14.
• FTC guidance on deceptive pricing and negative-option renewals.
• FDA warning-letter record for the excluded seller's parent company, June 2026.